Compare UIS & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UIS | CVRX |
|---|---|---|
| Founded | 1942 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.4M | 201.0M |
| IPO Year | N/A | 2021 |
| Metric | UIS | CVRX |
|---|---|---|
| Price | $2.86 | $7.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $5.88 | ★ $13.17 |
| AVG Volume (30 Days) | ★ 655.7K | 336.7K |
| Earning Date | 02-17-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,921,000,000.00 | $55,969,000.00 |
| Revenue This Year | N/A | $11.91 |
| Revenue Next Year | N/A | $15.28 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.44 |
| 52 Week Low | $2.37 | $4.30 |
| 52 Week High | $7.54 | $18.20 |
| Indicator | UIS | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 51.44 |
| Support Level | $2.88 | $5.11 |
| Resistance Level | $3.12 | $6.09 |
| Average True Range (ATR) | 0.16 | 0.79 |
| MACD | -0.03 | 0.10 |
| Stochastic Oscillator | 9.92 | 62.99 |
Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.